Quarterly report pursuant to Section 13 or 15(d)

1A. RESTATEMENT OF PREVIOUSLY REPORTED INFORMATION (Tables)

v3.3.1.900
1A. RESTATEMENT OF PREVIOUSLY REPORTED INFORMATION (Tables)
6 Months Ended
Oct. 31, 2015
Restatement of Prior Year Income [Abstract]  
Restatement of previously reported information

    October 31, 2015  
    As Previously Reported     Adjustment     As Restated  
Selected Consolidated Balance Sheet Accounts                        
Prepaid expenses and other current assets   $ 74,757     $ 335,878     $ 410,635  
Total current assets   $ 2,512,187     $ 335,878     $ 2,848,065  
Total assets   $ 7,641,661     $ 335,878     $ 7,977,539  
Additional paid in capital   $ 87,685,381     $ 914,270     $ 88,599,651  
Accumulated deficit   $ (81,200,061 )   $ (578,392 )   $ (81,778,453 )
Total stockholders' equity   $ 6,561,656     $ 335,878     $ 6,897,534  
Total liabilities and stockholders' equity   $ 7,641,661     $ 335,878     $ 7,977,539  

 

    Three Months Ended October 31, 2 015  
    As Previously Reported     Adjustment     As Restated  
Consolidated Statement of Operations                        
Total revenue   $     $     $  
Cost of revenue                  
Gross margin                  
Research and development costs     439,711             439,711  
Compensation expense     400,507             400,507  
Director fee     9,000             9,000  
Legal and professional     57,988             57,988  
General and administrative     222,039       506,573       728,612  
Loss from operations     (1,129,245 )     (506,573 )     (1,635,818 )
Unrealized gain on change in derivative     29,746       (29,746 )      
Other expenses     430             430  
Interest expense, net     (194 )           (194 )
Total other income (expense), net     29,982       (29,746 )     236  
Net loss   $ (1,099,263 )   $ (536,319 )   $ (1,635,582 )
                         
Basic and diluted net loss per share   $ 0.00     $     $ 0.00  

 

    Six Months Ended October 31, 2015  
    As Previously Reported     Adjustment     As Restated  
Consolidated Statement of Operations                        
Total revenue   $     $     $  
Cost of revenue                  
Gross margin                  
Research and development costs     595,389             595,389  
Compensation expense     848,077             848,077  
Director fee     27,000             27,000  
Legal and professional     183,063             183,063  
General and administrative     483,454       1,013,146       1,496,600  
Loss from operations     (2,136,983 )     (1,013,146 )     (3,150,129 )
Unrealized gain on change in derivative     492,049       (492,049 )      
Other expenses     335             335  
Interest expense, net     (826 )           (826 )
Total other income (expense), net     491,558       (492,049 )     (491 )
Net loss   $ (1,645,425 )   $ (1,505,195 )   $ (3,150,620 )
                         
Basic and diluted net loss per share   $ 0.00     $     $ 0.00  

 

    Three Months Ended October 31, 2015  
    As Previously Reported     Adjustment     As Restated  
Consolidated Statement of Comprehensive Loss                        
Net loss   $ (1,099,263 )   $ (536,319 )   $ (1,635,582 )
Foreign currency translation adjustment     (34 )           (34 )
Comprehensive loss   $ (1,099,297 )   $ (536,319 )   $ (1,635,616 )

 

 

    Six Months Ended October 31, 2015  
    As Previously Reported     Adjustment     As Restated  
Consolidated Statement of Comprehensive Loss                        
Net loss   $ (1,645,425 )   $ (1,505,195 )   $ (3,150,620 )
Foreign currency translation adjustment     1,587             1,587
Comprehensive loss   $ (1,643,838 )   $ (1,505,195 )   $ (3,149,033 )

 

 

    Six Months Ended October 31, 2015  
    As Previously Reported     Adjustment     As Restated  
                         
Consolidated Statement of Cash Flows                        
Operating activities                        
Net loss   $ (1,645,425 )   $ (1,505,195 )   $ (3,150,620 )
Stock issued for services           333,216       333,216  
Stock issued for compensation     254,040             254,040  
Stock based compensation - options     287,928             287,928  
Stock based compensation - warrants           679,930       679,930  
Gain on derivative liability     (492,049 )     492,049        
Increase in prepaid expenses and current assets     (80,500 )           (80,500 )
Decrease in accounts payable     (69,491 )           (69,491 )
Increase in accrued expenses     29,130             29,130  
Decrease in license agreement obligation     (400,000 )           (400,000 )
Net cash used in operating activities     (2,116,367 )           (2,116,367 )
                         
Investing activities                        
Net cash from investing activities                  
                         
Financing activities                        
Proceeds from sale of common stock     1,728,935             1,728,935  
Net cash provided by financing activities     1,728,935             1,728,935  
                         
Effect of currency rate exchange on cash     125             125  
                         
Net decrease in cash     (387,307 )             (387,307 )
Cash at beginning of year     2,699,737             2,699,737  
Cash at October 31, 2015   $ 2,312,430     $     $ 2,312,430